Saving Lives of Cancer Patients by Addressing Cancer-Associated Thrombosis

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...
Header image

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 24 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

The mission of ETHA is to give the thrombosis and hemostasis community a voice and drive prioritisation of thrombosis and hemostasis in the EU patient safety and research programs. With a united focus on raising awareness of bleeding and clotting disorders, ETHA stands together to work with the public as well as decision makers’ to provide input into EU health and patient safety strategies.

To learn more about ETHA’s initial area of priority, read the consensus statement, here.

News

Europe’s Beating Cancer Plan – Consultation Responses Su...

On 3 March, the European Thrombosis and Haemostasis Alliance (ETHA) submitted its consultation response on Europe’s Beating Cancer Plan to the European Commission and joined with the Cancer Related Complications and Comorbidit...

Continue reading

ETHA Signs a Joint Statement on Cancer Comorbidities

On 17 December 2019, the European Thrombosis and Haemostasis Alliance (ETHA) signed a joint statement as part of a new coalition on cancer comorbidities. Alongside ten signatories including the European Cancer Patient Coalition (ECP...

Continue reading